G. Vanherwaarden et al., SHORT-TERM-MEMORY IN PARKINSONS-DISEASE AFTER WITHDRAWAL OF LONG-TERMANTICHOLINERGIC THERAPY, Clinical neuropharmacology, 16(5), 1993, pp. 438-443
We assessed the short-term memory (STM) using the Visual Paired Associ
ates and the Verbal Paired Associates test, and the motor status at th
e end of 7.8 +/- 3.7 years of anticholinergic therapy in 22 nondemente
d patients with Parkinson's disease (PD). Eighteen patients managed to
stop anticholinergic therapy. During anticholinergic therapy, STM in
PD is significantly worse than in normal controls (CS). Two months aft
er the withdrawal of anticholinergic drugs, the STM retest gain is sig
nificantly greater in PD than in CS, and at that time STM in PD did eq
ual CS levels. After withdrawal of anticholinergic therapy, thirteen p
atients noticed a deterioration of motor function; the dose of levodop
a had to be increased in seven patients. We conclude that in nondement
ed PD patients, long-term anticholinergic therapy probably does not re
sult in irreversible damage to STM, and withdrawal of long-term antich
olinergic therapy is feasible in the majority of PD patients.